Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

News Details

(15/06/2026 15:40)

Avience Biomedicals announces launch of initial public offering

Avience Biomedicals Ltd. has announced public offering of 1453800 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 198.00 per share. The gross proceeds of the issue are expected to be Rs 3,023.90 lakhs.

The company's initial public offer (IPO) will open on 18 June 2026 and is expected to close on 22 June 2026, subject to customary closing conditions. The price band of the issue has been fixed at Rs 196.00-208.00 per share.

The IPO includes a fresh Issue of 1453800 Equity Shares of the Company at an price of Rs 208.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 600 shares with bids in multiples of 600.

Avience Biomedicals Ltd. anticipates using the proceeds of the issue for .

Fintellectual Corporate Advisors Pvt. Ltd. as lead manager & Skyline Financial Services Pvt. Ltd. is the registrar, to the issue.
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
CDSL – MyEasi App App Store: https://apps.apple.com/in/app/cdsl-myeasi-app/id6737304195      Google Play Store: https://play.google.com/store/apps/details?id=com.cdsl.myeasi   |   NSDL – Speede App : App Store: https://apps.apple.com/in/app/nsdl-speede-app/id922834763      Google Play Store: https://play.google.com/store/apps/details?id=com.msf.NSDL.Android